Provided herein are phosphadiazine polymerase inhibitor, for example, of anyof Formulas (IV), (IV), (I"), (II"), or (IVa), pharmaceutical compositionscomprising the compounds, and processes of preparation thereof. Also providedare methods of their use for the treatment of an HCV infection in a host in need thereof.